Molidustat; BAY-85-3934; 1,?2-?dihydro-?2-?[6-?(4-?morpholinyl)-?4-?pyrimidinyl]-?4-?(1H-?1,?2,?3-?triazol-?1-?yl)-?3H-?pyrazol-?3-?one

名称与同义词

• Molidustat
• 1154028-82-6
• molidustatum
• musredo
• Molidustat sodium
• Molidustat [INN]
• Molidustat [USAN]
• Varenzin-CA1
• BAY 85-3934
• MOLINATE
• Molidustat (BAY85-3934)
• RefChem:57794
• UNII-9JH486CZ13
• Molidustat (USAN/INN)
• Molidustat [USAN:INN]
• Molidustat(BAY 85-3934)
• D01SPD
• D0EJ7U
• 9JH486CZ13
• MOLIDUSTAT [WHO-DD]
• Molidustat (BAY 85-3934)
• Molidustat(BAY85-3934)
• DTXSID80151089
• BAY-85-3934
• IJMBOKOTALXLKS-UHFFFAOYSA-N
• GTPL8456
• orb1701289
• SCHEMBL2569970
• SCHEMBL6114312
• BAY85-3934
• CHEMBL3646118
• DTXCID0073580
• Molidustat (Bay-85-3934)
• SCHEMBL29357358
• CPP-115
• EX-A562
• Molidustat(BAY 85-3934)?
• MFCD28411428
• BDBM118339
• C13H14N8O2
• GLXC-90283
• AOB87194
• BCP14477
• EWB02882
• MSK11079
• WHO 9655
• HIF-PH inhibitors (anemia), Bayer
• AKOS026750584
• ZINC167006010
• BAY-853934
• CCG-267626
• CS-4046
• EBC-251092
• SB17156
• 2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(triazol-1-yl)-1H-pyrazol-3-one
• NCGC00388364-04
• AC-35448
• AK323698
• AS-74456
• BC600706
• HY-12654
• QC-11791
• DB-092822
• DB-132052
• B5861
• S8138
• J3.735.470H
• <p>Molidustat</p>
• 3H-Pyrazol-3-one, 1,2-dihydro-2-[6-(4-morpholinyl)-4-pyrimidinyl]-4-(1H-1,2,3-triazol-1-yl)-
• A14404
• D12122
• BAY 85-3934;BAY-85-3934
• US8653111, 72
• BRD-K01291782-001-01-1
• Q27087553
• 2-[6-(4-Morpholinyl)-4-pyrimidinyl]-4-(1H-1,2,3-triazol-1-yl)-1,2-dihydro-3H-pyrazol-3-one
• 1-(6-morpholinopyrimidin-4-yl)-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-ol
• 2-(6-(Morpholin-4-yl)pyrimidin-4-yl)-4-(1H-1,2,3-triazol-1-yl)-1,2-dihydro-3H-pyrazol-3-one
• 2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(1,2,3-triazol-1-yl)pyrazol-3-ol
• 2-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-2,3-dihydro-1H-pyrazol-3-one
• Hypoxia-inducible factor prolyl hydroxylase inhibitors (anemia)
• 2-(6-Morpholin-4-Ylpyrimidin-4-Yl)-4-(1,2,3-Triazol-1-Yl)-1~{h}-Pyrazol-3-One
• 2-(6-morpholinopyrimidin-4-yl)-4-(triazol-1-yl)-1H-pyrazol-3-one
• 2-(6-Morpholinopyrimidin-4-yl)-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-3(2H)-one
• Molidustat;BAY 85-3934;BAY-85-3934; BAY 853934; BAY-853934; BAY853934
• Vigabatrin derivatives (oral, neurological diseases), Northwestern University
• 1375799-61-3
• 2-(6-(morpholin-4-yl)pyrimidin-4-yl)-4-(1H-1,2,3-triazol-1-yl)-2,3-dihydro-1H-pyrazol-3-one
• 2-(6-Morpholin-4-ylpyrimidin-4-yl)-4-(1H-1,2,3-triazol-1-yl)-1,2-dihydro-3H-pyrazol-3-one
• 2-[6-(Morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1,2-dihydro-3H-pyrazol-3-one
• 3H-PYRAZOL-3-ONE, 1,2-DIHYDRO-2-(6-(4-MORPHOLINYL)-4-PYRIMIDINYL)-4-(1H-1,2,3-TRIAZOL-1-YL)-
• A1H
• GABA aminotransferase inhibitors (oral), Northwestern University/Catalyst Pharmaceutical Partners
• Molidustat; BAY-85-3934; 1,?2-?dihydro-?2-?[6-?(4-?morpholinyl)-?4-?pyrimidinyl]-?4-?(1H-?1,?2,?3-?triazol-?1-?yl)-?3H-?pyrazol-?3-?one
• QEQ
• Vigabatrin derivatives (oral, drug addiction/epilepsy/neuropathic pain), Catalyst Pharmaceutical Partners